Internal Medicine · Nashville, TN
NPI
1215193255
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3601 the Vanderbilt Clinic
Nashville, TN, 37232
Phone (615) 322-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
615 services
Medicare patients, 2024
192
Average age 72
Drug cost, 2024
$5.3M
796 prescriptions
Company payments, 2025
$0
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sanjay R Mohan was code 99232 (hospital e&m - subsequent), 141 times for 41 patients. In total Sanjay R Mohan billed 615 services in 13 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 141 | 41 | $56.98 | $8,035 |
| 99214 Office E&M - Established | Facility | 141 | 75 | $65.91 | $9,293 |
| 99215 Office E&M - Established | Facility | 113 | 65 | $94.01 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 90 | 27 | $70.01 | $6,301 |
| 99238 Hospital Discharge Management | Facility | 36 | 31 | $57.57 | $2,073 |
| 99213 Office E&M - Established | Facility | 28 | 20 | $42.73 | $1,197 |
| 99222 Hospital E&M - Initial | Facility | 19 | 17 | $96.04 | $1,825 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $118.01 | $1,298 |
By year: 2022 $48K for 642 services; 2023 $34K for 456 services; 2024 $45K for 615 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sanjay R Mohan prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 108 prescriptions and refills. In total Sanjay R Mohan wrote 796 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 108 | 108 | 11 | $1.8M |
| Hydroxyurea Generic | 81 | 184 | 20 | $1,807 |
| Sprycel Dasatinib | 40 | 40 | Under 11 | $531K |
| Ondansetron Hcl Generic | 36 | 36 | 13 | $183 |
| Venclexta Venetoclax | 36 | 36 | Under 11 | $85K |
| Promacta Eltrombopag Olamine | 31 | 31 | Under 11 | $665K |
| Prednisone Generic | 28 | 66 | Under 11 | $137 |
| Rydapt Midostaurin | 24 | 26 | Under 11 | $300K |
| Levofloxacin Generic | 19 | 27 | 11 | $392 |
| Tasigna Nilotinib Hcl | 17 | 17 | Under 11 | $310K |
| Methotrexate Methotrexate Sodium | 15 | 15 | Under 11 | $149 |
| Imatinib Mesylate Generic | 15 | 15 | Under 11 | $2,947 |
| Lenalidomide Generic | 14 | 14 | Under 11 | $177K |
| Azithromycin Generic | 13 | 13 | Under 11 | $55.73 |
| Gabapentin Generic | 13 | 13 | Under 11 | $222 |
Brand drugs: 343 claims; generic drugs: 453 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sanjay R Mohan $0 (- in general payments such as food, travel and fees) from 3 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.